MedTrace Logo

Interaction of Statins and Nondepolarizing Muscle Relaxants

NCT02222519 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2014-10-23

No results posted yet for this study

Summary

provide evidence for prevention or reduction muscle pain.

Conditions

Interventions

DRUG

Rocuronium

Rocuronium 0.6mg/kg iv single dose

Sponsors & Collaborators

  • Huang-wei LV

    lead OTHER

Principal Investigators

  • Huangwei Lv, Professor · the Anesthesiology Department

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02222519 on ClinicalTrials.gov